Published on 8/28/2009 in the Prospect News PIPE Daily.
New Issue: Trubion Pharmaceuticals seals $10 million private placement of equity
By Devika Patel
Knoxville, Tenn., Aug. 28 - Trubion Pharmaceuticals, Inc. settled a $10 million private placement of stock on Aug. 27, according to an 8-K filed Friday with the Securities and Exchange Commission.
The company sold 2,243,649 common shares at $4.457025 apiece to Facet Biotech Corp.
Seattle-based Trubion develops products to treat autoimmune disease and cancer.
| Issuer: | Trubion Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $10 million
|
| Shares: | 2,243,649
|
| Price: | $4.457025
|
| Warrants: | No
|
| Investor: | Facet Biotech Corp.
|
| Settlement date: | Aug. 27
|
| Stock symbol: | Nasdaq: TRBN
|
| Stock price: | $3.83 at close Aug. 27
|
| Market capitalization: | $106 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
